arrow
J

Joachim Yahalom

Memorial Sloan Kettering Cancer Center
H指数:83
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma:

在风险较高的早期霍奇金淋巴瘤中,省略放射治疗与较差的疾病控制相关

2026-01-010
OAAI
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

异基因抗原受体T细胞治疗前的桥接放射疗法用于B细胞淋巴瘤:一项ILROG多中心研究

2025-04-110
OA
Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

分子特征与弥漫性大B细胞淋巴瘤的疾病分期相关,并揭示了患者预后的异质性。

BLOOD
IF23.1
2024-11-050
PRE
Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma

巩固治疗方案及原发性中枢神经系统淋巴瘤患者的脑萎缩

2024-11-011
PRE
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

具有MYC,BCL2和/或BCL6重排的有限阶段高级别b细胞淋巴瘤: BCL2重排导致不良结果

2024-10-140
OAAI
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good long-term outcomes
2023-08-312
OAAI
Retrospective characterization of nodal marginal zone lymphoma
2023-08-244
OAAI
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy

在嵌合抗原受体T细胞治疗之前,快速有效地桥接辐射可减少高危复发/难治性侵袭性b细胞淋巴瘤

2023-04-0134
OAAI
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
LEUKEMIA
IF13.4
2022-11-0536
OA
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)
2022-08-017
OAAI
Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines
2022-04-0142
OA
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
2022-02-102
OAAI